These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8691250)

  • 1. Genetic risk assessment after iodine-131 exposure: an opportunity and obligation for nuclear medicine.
    Dottorini ME
    J Nucl Med; 1996 Apr; 37(4):612-5. PubMed ID: 8691250
    [No Abstract]   [Full Text] [Related]  

  • 2. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients.
    Schlumberger M; De Vathaire F; Ceccarelli C; Delisle MJ; Francese C; Couette JE; Pinchera A; Parmentier C
    J Nucl Med; 1996 Apr; 37(4):606-12. PubMed ID: 8691249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of pregnancy in women with thyroid carcinoma.
    Schlumberger M; De Vathaire F; Ceccarelli C; Francese C; Pinchera A; Parmentier C
    J Endocrinol Invest; 1995 Feb; 18(2):150-1. PubMed ID: 7629385
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-cancer EMF effects related to children.
    Feychting M
    Bioelectromagnetics; 2005; Suppl 7():S69-74. PubMed ID: 16142774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid stunning.
    Medvedec M
    J Nucl Med; 2001 Jul; 42(7):1129-31. PubMed ID: 11438638
    [No Abstract]   [Full Text] [Related]  

  • 6. Stunning after tracer dosimetry.
    Diehl M; Grünwald F
    J Nucl Med; 2001 Jul; 42(7):1129. PubMed ID: 11438639
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of malignant thyroid tumors in humans after exposure to diagnostic doses of iodine-131. I. Retrospective cohort study.
    Holm LE; Lundell G; Walinder G
    J Natl Cancer Inst; 1980 May; 64(5):1055-9. PubMed ID: 6929011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioactive iodine and thyroid tumors].
    Fromigué J; Bachelot A; Baudin E; Schlumberger M
    Pathol Biol (Paris); 2002 Apr; 50(3):157-60. PubMed ID: 11980328
    [No Abstract]   [Full Text] [Related]  

  • 9. Radioiodine therapy and subsequent pregnancy.
    Brandão CD; Miranda AE; Corrêa ND; Sieiro Netto L; Corbo R; Vaisman M
    Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):534-40. PubMed ID: 17684613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome after 131I therapy.
    Sioka C; Fotopoulos A
    J Nucl Med; 2009 Feb; 50(2):327; author reply 327-8. PubMed ID: 19164224
    [No Abstract]   [Full Text] [Related]  

  • 11. Prenatal diagnosis of fetal hypothyroidism after maternal radioactive iodine exposure during pregnancy.
    Basbug M; Ozgun MT; Murat N; Batukan C; Ozcelik B; Kurtoglu S
    J Clin Ultrasound; 2010; 38(9):506-8. PubMed ID: 20806345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
    Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
    J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of thyroid cancer.
    Blahd WH
    Compr Ther; 1985 Sep; 11(9):26-32. PubMed ID: 4042593
    [No Abstract]   [Full Text] [Related]  

  • 14. [131 iodine for the initial treatment of thyroid cancer].
    Delisle MJ; Clerc J
    Ann Endocrinol (Paris); 1997; 58(3):197-203. PubMed ID: 9239241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer.
    Garsi JP; Schlumberger M; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henry-Amar M; Bardet S; Rubino C; De Vathaire F
    Clin Endocrinol (Oxf); 2009 Dec; 71(6):880-3. PubMed ID: 19250267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid cancer radioiodine therapy: health service performance and radiation safety.
    Vogiatzi S; Liossis A; Lamprinakou M
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):434-8. PubMed ID: 25809109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carcinogenic effects of radioiodine therapy for thyroid carcinoma.
    de Vathaire F
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):180-1. PubMed ID: 18283326
    [No Abstract]   [Full Text] [Related]  

  • 18. Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
    Reiners C; Biko J; Haenscheid H; Hebestreit H; Kirinjuk S; Baranowski O; Marlowe RJ; Demidchik E; Drozd V; Demidchik Y
    J Clin Endocrinol Metab; 2013 Jul; 98(7):3039-48. PubMed ID: 23616148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perspective on post-Chernobyl radioablation in young females.
    Reiners C; Lassmann M; Hänscheid H
    J Nucl Med; 2006 Oct; 47(10):1563-4. PubMed ID: 17015887
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma.
    Fard-Esfahani A; Hadifar M; Fallahi B; Beiki D; Eftekhari M; Saghari M; Takavar A
    Hell J Nucl Med; 2009; 12(1):37-40. PubMed ID: 19330181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.